Following its latest meeting, the EMA's CHMP has suggested granting marketing authorisation to seven medicines and extending the indications of 15 others.
List view / Grid view
Filter the results
Dapivirine Vaginal Ring (dapivirine) and Blenrep (belantamab mafodotin) have been recommended for approval by the EMA's CHMP, along with nine other medicines.
The EMA's human medicines committee has adopted a positive opinion for eight medicines, recommending their marketing authorisation.